Biden-Harris administration provides at least 80 million COVID-19 vaccines for the world
The White House
These actions will: Protect Americans. Put us on the path to ending the pandemic. Reduce the variations. Show leadership.
Today, the President reaffirmed his commitment to lead an international and coordinated vaccination effort, announcing that the United States will donate 80 million American vaccines – the 60 million doses of AstraZeneca vaccine previously announced and at least 20 million. of additional doses of vaccines authorized in the United States by the end of June. The United States will continue to donate our excess supply as it arrives to us. Today’s announcement is the administration’s next step as we step up our efforts to respond to COVID-19 around the world. Over the coming weeks, the United States will use its leadership by working with our G7 partners, the EU, COVAX and others to coordinate a multilateral effort focused on ending the pandemic. Specifically, we seek to garner concrete and achievable commitments from other governments and private sector partners to make more vaccines available, boost the production and manufacture of vaccines and raw materials, get shots in. around the world and provide health security assistance to save lives, stop the spread of COVID-19, reduce the lifespan of this pandemic, and recover economically.
Serving to end the pandemic everywhere
- The United States will work with COVAX and other partners to ensure that these vaccines are delivered in a fair manner and in accordance with scientific and public health evidence. The United States will not use its vaccines to gain favor from other countries.
- In the coming weeks, working with democracies around the world, the Biden-Harris administration will coordinate a multilateral effort to end the pandemic. We look forward to progress in this area at the G7 summit in June.
- It’s a unique moment in history, and it takes American leadership, science and ingenuity, perseverance and the democracies of the world to get to work.
Sharing America’s Surplus Vaccine Doses to Save Lives
- COVID-19 is a global challenge that requires a global response. The United States and the world will never be safe when this pandemic rages around the world. New variations will continue to appear – putting us all at risk.
- Because the United States has done so much in the United States, we can continue to do more to help the world by playing a leadership role in ending the pandemic globally and in building a coordinated multilateral effort around the world to end the pandemic.
- Our overriding goal is to get as many safe and effective vaccines to as many people as possible as quickly as possible.
- The United States will send 80 million American vaccines to help countries battling the pandemic by the end of June 2021. This equates to its full 60 million doses of AstraZeneca vaccine made as soon as they are reviewed by the United States. FDA, as well as at least another 20 million doses of vaccines approved for use in the United States. We will continue to donate our excess supply as it is delivered to us.
- As President Biden said, just as America was the arsenal of democracy during WWII – in this battle against the COVID-19 pandemic, our nation will be the arsenal of vaccines.
Decision builds on existing US leadership in global response to COVID
- $ 11.5 billion in new funds to support countries’ response to COVID-19. The United States has expanded its support to countries in the fight and recovery of COVID-19 around the world with $ 11.5 billion from Congress in the US bailout.
- The COVID-19 TRIPS exemption. Extraordinary times call for extraordinary measures. The United States supports lifting of intellectual property protection for COVID-19 vaccines due to the extraordinary circumstances of the pandemic.
- Special Drawing Rights (SDRs) for COVID-19 recovery. The Treasury Department is working with the management of the International Monetary Fund and other members towards a general allocation of $ 650 billion SDR to IMF member countries to support the global recovery from the COVID-19 crisis, this which would also increase demand for US exports and support US businesses and job creation in the United States.
- Global manufacture of vaccines and production of raw materials. The United States is working with the private sector and all possible partners to expand the global manufacture and distribution of vaccines, as well as the production of vital raw materials. For example, the US International Development Finance Corporation has launched a global vaccine initiative that targets investments in multiple regions of the world both to meet short-term crisis response needs and medium-term efforts to ensure better global readiness for future health challenges. . This includes, but is not limited to, the U.S. Quad Vaccine partnership to deliver at least one billion doses of COVID-19 vaccines by the end of 2022, including the Johnson & Johnson vaccine.
- Emergency aid to countries in need. The United States recently sent six flights and up to $ 100 million in aid to India and is supporting new assistance to South Asia and Latin America as countries experience surges.
- Re-engagement with the World Health Organization (WHO). On the first day, President Biden reconnected with the WHO and pledged to strengthen and reform the organization.
- Advance global health security and the global health security agenda, including by leading – with the G-20 and other partners, efforts to reach consensus in 2021 on the establishment of a sustainable funding mechanism for global health security, triggers, independent oversight and accountability for leaders to act unhesitatingly when a biological threat emerges; regional surge capacity for vaccines, personal protective equipment, diagnostics and therapeutics; and a globally responsive biomonitoring system.